NSpine is the UK's most comprehensive spine course; a unique learning environment which amalgamates the latest research and surgical practice in the treatment of the spine. We gather the leading lights across a broad spectrum of spinal disciplines to advance your knowledge.
Next event: June 2017
Date: Sat 18th February 2017
Venue: Nuffield Orthopaedic Centre, Oxford
Date: Fri 24th February 2017
Venue: Blenheim Palace, Oxford
As another ankle prosthesis is decommissioned from the UK market, the surgical community is once again prompted to reassess their options when it comes to performing total ankle replacements.
We aim to provide stimulating discussion and debate by addressing some of the 'Key Questions' with an opportunity to exchange views and techniques with colleagues on the current status of total ankle replacement.
This event was limited to a very small number of candidates to provide outstanding faculty to delegate to specimen ratios, as was regarded as a phenomenal success.
The Southwest Sarcoma meeting for 2014 was held in Oxford. Attendees enjoyed an interesting programme involving case discussions, key debates in challenging areas and a guest address at the end of the day.
This meeting was an exceptional opportunity to be able to see and discuss a variety of difficult cases and scenarios that are faced by both the primary and revision hip surgeon. Our expert faculty gave their own thoughts as to how they would deal with each scenario.
Complex revision scenario session was held in the afternoon with a strong focus on debate and discussion.
This two day course featured lectures from an esteemed international faculty as well as the opportunity for hands on group work and practice for vivas.
This course was aimed at any Orthopaedic Surgeon, Oncologist, Radiologist or other professional involved in the treatment of those with metastatic skeletal disease. We put together an expert faculty to examine some of the challenges currently faced by treating surgeons and physicians particularly in light of the increasing life expectancy associated with some malignancies. The day was an exciting mix of presentations and case discussions culminating in an address by Sir Michael Rawlins, Chairman of NICE.